Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide

International Journal of Experimental Pathology

Volumn 86, Issue 6, 2005, Pages 375-382

  Ribeiro, Daniel A ^a   Salvadori, Daisy M F ^a   Marques, Mariângela E A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

4 nitroquinoline 1 oxide; bax; bcl 2; Oral cancer

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; CARCINOGEN; DRINKING WATER; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUTH CANCER; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TONGUE;

EID: 28544439974     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2005.00444.x     Document Type: Article

References (37)

1. Akao Y., Otsuki Y., Kataoka S., Ito Y., Tsujimoto Y. (1994) Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 54, 2468-2471.
2. Arends MJ. & Wyllie A.H. (1991) Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32, 223-254.
3. Chen Y., Kayano T., Takagi M. (2000) Dysregulated expression of bcl-2 and bax in oral carcinomas: evidence of post-transcriptional control. J. Oral Pathol. Med. 29, 63-69.
4. Gastman B.R. (2001) Apoptosis and predisposition to oral cancer. Head Neck 23, 409-425.
5. Gazzaniga P., Gallucci M., Gradilone A. et al. (1995) Detection of BCL-2 RNA in low grade tumours of the urinary bladder. Eur. J. Cancer 31A, 2119-2120.
6. Hahn M., Hagedorn G., Kuhlisch E., Schackert H.K, Edkelt U. (2002) Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol. 38, 486-490.
7. Harada H., Mitsuyasu T., Seta Y., Maruoka Y., Toyoshima K., Yasumoto S. (1998) Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J. Oral Pathol. Med. 27, 11-17.
8. Ikegaki N., Katsumata M., Minna J., Tsujimoto Y. (1994) Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res. 54, 6-8.
9. Jordan R.C.K., Catzavelos G.C., Barrett A.W., Speight P.M. (1996) Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncol. 32B, 394-400.
10. Kapucuoglu N., Losi L., Eusebi V. (1997) Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas. Virchows Arch. 430, 17-22.
11. Korsmeyer S.J., Shutter J.R., Veis D.J., Merry D.E., Oltvai Z.N. (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Cancer Biol. 4, 327-332.
12. Krajewska M., Fenoglio-Preiser C.M., Krajewski S. et al. (1996) Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am. J. Pathol. 149, 1449-1457.
13. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H.G., Reed J.C. (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145, 1323-1336.
14. Kramer I.R., Lucas R.B., Pindborg J.J. (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. Oral Med. Oral Pathol. 46, 518-539.
15. Lauwers G.Y., Scott G.V., Hendricks J. (1994) Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 73, 2900-2904.
16. Loro L.L., Johannessen A.C., Vintermyr O.K. (2002) Decreased expression of bcl-2 in moderate and severe oral dysplasias. Oral Oncol. 38, 691-698.
17. Lu Q.L., Abel P., Foster C.S., Lalani E.N. (1996) Bcl-2: role in epithelial differentiation and oncogenesis. Hum. Pathol. 27, 102-110.
18. Lu Q.L., Elia G., Lucas S., Thomas J.A. (1993) Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated naso-pharyngeal carcinoma. Int. J. Cancer 53, 29-35.
19. Magrath I. & Litvak J. (1993) Cancer in developing countries: opportunity and challenge. J. Natl. Cancer Inst. 85, 862-874.
20. Manetto V., Lorenzini R., Cordon-Cardo C. et al. (1997) Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis. Virchows Arch. 430, 125-130.
21. McAlinden R.L., Maxwell P., Napier S. et al. (2000) Bcl-2 expression in sequential biopsies of potentially malignant oral mucosal lesions assessed by immunocytochemistry. Oral Dis. 6, 318-326.
22. Nauta J.M., Roodenberg J.L.N., Nikkels P.G.J., Witjes M.J.H., Vermey A. (1995) Comparison of epithelial dysplasia - the 4NQO rat palate model and human oral mucosa. Int. J. Oral Maxillofac Surg. 24, 53-58.
23. Nishimura A. (1999) Changes in Bcl-2 and Bax expression in rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. J. Dent. Res. 78, 1264-1269.
24. Niwa S., Ueno S., Shirasu R. (2001) Alteration of pRB expression in the development of rat tongue carcinoma induced by 4-nitroquinoline 1-oxide. Oral Oncol. 37, 579-585.
25. Nylander K., Schildt E.B., Eriksson M., Roos G. (1997) PCNA, Ki-67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck. Anal. Cell Pathol. 14, 101-110.
26. Ohne M., Satoh T., Yamada S., Takai H. (1985) Experimental tongue carcinoma of rats induced by oral administration of 4-nitroquinoline 1-oxide (4NQO) in drinking water. Oral Surg. Oral Med. Oral Pathol. 59, 600-607.
27. Okazaki Y., Tanaka Y., Tonogi M., Yamane G. (2002) Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol. 38, 562-573.
28. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. (1993) Bcl-2 hetero-dimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
29. Polverini PJ. & Nor J.E. (1999) Apoptosis and predisposition to oral cancer. Crit. Rev. Oral Biol. Med. 10, 139-152.
30. Ravi D., Nalinakumari K.R., Rajaram R.S., Nair M.K., Pillai M.R. (1996) Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett. 105, 139-146.
31. Schoelch M.L., Le Q.T., Silverman S. Jr et al. (1999) Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol. 35, 77-85.
32. Singh B.B., Chandler F.W. Jr, Whitaker S.B., Forbes-Nelson A.E. (1998) Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85, 692-698.
33. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens L.C., Lee J.J., Levin B. (1995) Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241.
34. Tanaka T., Kohno H., Sakata K. et al. (2002) Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Carcinogenesis 23, 1361-1367.
35. Tsujimoto Y., Jaffe E., Cossman J., Gorham J., Nowell P.C., Croce C.M. (1985) Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 315, 340-343.
36. Vered M., Daniel N., Hirshberg A., Dayan D. (2003) Histomorphologic and morphometric changes in minor - salivary glands of the rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. Oral Oncol. 39, 491-496.
37. Xi S. & Grandis J.R. (2003) Gene therapy for the treatment of oral squamous cell carcinoma. J. Dent. Res. 82, 11-16.